Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study
Núbia Muñóz(Instituto Nacional de Cancerología), F. Xavier Bosch(Vall d'Hebron Hospital Universitari), Rolando Herrero(Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud), Vı́ctor Moreno(Ajuntament de L’Hospitalet), Jennifer S. Smith(University of North Carolina at Chapel Hill), Chris J.L.M. Meijer(Dutch Cancer Society), Cristina Bosetti(Joint Research Centre), Keerti V. Shah(Institut Català d'Oncologia), Silvia Franceschi(Centro di Riferimento Oncologico)
Cited by 718
Related Papers
Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective
|JNCI Journal of the National Cancer Institute|1995|3.4k
Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review
|Cancer Epidemiology Biomarkers & Prevention|2005|2.2k
SNPStats: a web tool for the analysis of association studies
|Bioinformatics|2006|2k
Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update
|International Journal of Cancer|2007|1.7k
Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis
|The Lancet Infectious Diseases|2007|1.7k